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Abstract
Background: Coronary sinus rupture (CSR) is a rare preventable complication of cannula insertion for retrograde cardioplegia. In the 
hands of an inexperienced surgeon, this complication has the risk of potential mortality and morbidity, and its repair is technically 
challenging. Techniques for repairing CSR have been reported previously. In this study, we determined predictors of CSR following 
coronary artery bypass graft (CABG) surgery.
Methods: Over a four-year period, we retrospectively analyzed 1500 patients in whom a retrograde coronary sinus catheter was used to 
administer cardioplegic solution. CSR occurred in 15 patients. (12 women and 3 men). Variables such as age, weight, body mass index, 
gender, aortic clamp time, pump time, cardiomegaly, ejection fraction, and number of grafts were determined for each patient. Factors 
correlated with CSR were analyzed using multiple regression analysis, and odd ratios of significant variables were determined.
Results: In multiple regression analysis, factors such as female gender, age, weight, and body mass index showed a significant correlation 
with CSR, and their odd ratios were 4.2, 1.0, 0.96, and 2.2, respectively.
Conclusion: In all 15 cases, a retrograde cannula with a self-inflatable balloon was used and 12 patients were woman with low body 
mass index. Forceful insertion due to coronary sinus web, fragility of arteries in thin patients, or a small coronary sinus caused CSR in 
the hands of an inexperienced surgeon.
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Introduction
Delivery of cardioplegia via the coronary sinus was 
first described by Melrose in 1955.1 Lillihei et al2 sub-
sequently used the same method routinely for heart 
protection. The advantage of this method is steady 
homogenous delivery and distribution of cardioplegia 
in the presence of proximal coronary artery stenosis or 
occlusion. This route of delivery also avoids the prob-
lem of stunning or an island of poorly protected myo-
cardium,  which  can  occur  with  antegrade  delivery. 
The mechanism of myocardial protection due to retro-
grade cardioplegia is similar to that for the antegrade 
method, in that both techniques can provide nutritive 
flow and myocardial cooling. However, the two routes 
differ in their distribution. Retrograde flow via the 
coronary sinus distributes to subendocardial muscle 
tissue whether coronary artery stenosis is present or 
not, and distributes preferentially in the left ventricle, 
with decreased flow to the septum and right ventri-
cle. Despite this decreased flow to the right side of 
the heart, retrograde delivery of cardioplegia provides 
effective cooling of the right ventricle and septum.3
In  redo  CABG  surgery,  injection  of  antegrade 
cardioplegia causes atherosclerotic plaque emboli of 
grafts while the injection of retrograde cardioplegia 
causes washing of small atherosclerotic plaque out of 
the arterial system and allows the arterial graft to be 
deaired in a retrograde fashion.4
In  patients  with  aorta  regurgitation,  injection 
of cardioplegia into the aorta root does not provide 
adequate  aortic  root  pressure  butdoes  not  cause 
diastolic arrest, so retrograde injection can be used 
to  protect  the  heart.  An  additional  advantage  of 
retrograde cardioplegia is the ability to deliver it while 
performing key technical components of an operation. 
For example, during mitral valve surgery, retrograde 
cardioplegia  may  be  given  without  the  need  to 
reposition the retractor because myocardial protection 
is no longer dependent on a component aortic valve, 
as it wouldbe in the case of antegrade delivery, thus 
allowing uninterrupted progression of surgery.5
The  disadvantage  of  retrograde  cardioplegia 
includes possible injury to the coronary sinus by the 
catheter,  stylet  or  balloon,  myocardial  injury  with 
edema and hemorrhage if cardioplegia is delivered at 
a pressure higher than 50 mmHg, and the possibility 
of inadequate protection of the right ventricle.5 In fact, 
some anterior parts of the right ventricle and parts of 
both atria would not drain from the coronary sinus, 
and the small cardiac vein would drain most of the 
blood from the anterior part along the marginal artery 
(in the atrioventricular groove) into the right atrium.
The the besius vein enters into the right atrium 
directly and sometimes enters into the right   ventricle. 
In  the  absence  of  an  anomalous  venous  system, 
  retrograde injection of cardioplegia will not protect 
the right ventricle. In the case of anomalous systemic 
veins, distribution of cardioplegia via the retrograde 
route will not be uniform, so it cannot protect the 
heart so well.6
Considering the above advantages and disadvan-
tages, there is no uniform agreement about routine 
use of retrograde cardioplegia in patients undergoing 
coronary artery bypass grafting (CABG) due to the 
potentially lethal complication of coronary sinus rup-
ture (CSR) and poor protection of the right ventricle. 
A considerable number of studies have been reported 
in the literature, but most are case reports about tech-
niques for CSR repair. In this retrospective clinical 
study, we attempted to identify predictors of CSR fol-
lowing CABG. Ethical approval for this research was 
received from the Imamali Heart Center and Imamali 
Hospital.
Materials and Methods
A total of 1500 patients who underwent CABG with 
retrograde cardioplegia at our center over a four-year 
period  from April  1,  2003  to April  1,  2007  were 
studied  retrospectively.  Patients  who  underwent 
CABG   without cardiopulmonary bypass or had com-
bined  surgery  were  excluded.  Patients  with  CSR 
(Group A) were compared with a control group of 
1465  patients  who  did  not  have  CSR  (Group  B). 
Twenty patients were excluded because of reported 
difficulty in retrograde cannula insertion. We designed 
a retrospective study to identify predictors of CSR 
after open heart surgery. Variables such as age, gen-
der, body mass index, body weight, number of grafts, 
ejection  fraction,  hypertension,  aortic  cross  clamp 
time, pump time, left main coronary artery disease, 
and location of rupture were determined.
A  standardized  cardiopulmonary  bypass  proto-
col  was  used.  Cardiopulmonary  bypass  was  estab-
lished  by  cannulation  of  the  right  atrium  and  an 
arterial cannula was placed in the ascending aorta. 
Medtronic  DLP  pulsating  cardiopulmonary  bypass 
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was   performed with mild core hypothermia (35 °C) 
using a hollow fiber membrane oxygenator (Sorine, 
Italy).   Intermittent antegrade cold blood cardioplegia 
was  delivered  through  a  10  gauge  aortic  root  can-
nula, and a Medtronic retrograde cannula was placed 
for myocardial protection. A coronary sinus cannula 
with a passively inflated (Auto inflated Edward life 
  sciences),  or  manual  inflated  balloon  (Medtronic, 
DLP 13–15)was placed via a mattress suture in the lat-
eral wall of the right atrium. The cardioplegic mixture 
consisted of 50% St. Thomas’ cardioplegic solution 
and 50% autologous blood. A dose of 15 mL/kg was 
delivered antegradely to induce diastolic arrest and 
3 mL/kg was administered from a retrograde cannula.
Statistical analysis
Statistical analyses were carried out using the SPSS sta-
tistical software package 10 (SPSS Inc., Chicago, IL). 
All data were expressed as means ± standard   deviation. 
Categorical and continuous variables were compared 
using  the  χ2  test  and  t-test,  respectively. Variables 
with a P value ,0.05 were entered in multivariate 
regression analysis and odds ratios of significant vari-
ables were determined. Differences were considered 
significant at P , 0.05.
Results
Patient characteristics are shown in Tables 1 and 2. 
There were significant differences between group A 
and Group B with respect to variables such as gender, 
age, body mass index, ejection fraction, postoperative 
myocardial  infarction,  congestive  heart  failure, 
  preoperative  creatinine  .1.5,  chronic  obstructive 
pulmonary  disease,  infection,  pulmonary  complica-
tions, and death (P , 0.05). CSR was documented in 
15 patients (15 of 1465, 1.02%) who received retro-
grade cardioplegia for heart   protection, two of whom 
died, and CSR was repaired according to standard sur-
gical methods in the remaining 13 patients. There was a 
significant difference in the incidence of postoperative 
complications between the two groups. Postoperative 
infections occurred in 13.5% of patients in Group A 
and in 3.5% patients in Group B (P , 0.05). The aver-
age length of stay for Group A was 17.5 ± 5.5 days and 
14.5 ± 7.5 days for Group B. There were two postoper-
ative deaths in Group A (13.3%) and 38 postoperative 
deaths (2.6%) in Group B. Postoperative pulmonary 
complications  occurred  in  two  patients  (14%)  in 
Group A and in 64 patients (4.4%) in Group B.
The mean age of the patients was 73.2 ± 2.87 years 
in Group A and 54 ± 8.37 years in Group B. In Group A, 
12 patients were female and two patients were male. 
Mean body weight was 72.3 ± 11.5 kg in Group A and 
67.5 ± 12.3 kg in Group B. Twenty percent of CSR 
occurred  in  the  proximal  portion  (1.5  cm  from  the 
entrance to the coronary sinus), 70% were in the middle 
third, and 10% in the distal third of the coronary sinus. 
Two patients underwent beating onpump CSR repair. 
Table 1. Comparison of preoperative variables between group A and group B using t-test and χ2.
Variable Group A  
(csR)
Group B  
(no csR)
P value
Age 54 ± 8.37 73.2 ± 2.87 ,0.05
Female 12/15 (80%) 480/1465 (32.7%) ,0.05
Left main stem 13.4% 14.8% nS
ejection fraction
 , 35%
 . 35%
 
81.5% 
18.5%
 
48.2% 
51.8%
,0.05 
,0.05
Postoperative myocardial infarction 14.8% 4.3% ,0.05
Congestive heart failure 22.2% 3.9% ,0.05
Diabetes 20.4% 18.5% nS
Stroke 1.4% 1.8% nS
Preoperative creatinine .1.5 17.5% 3.4% ,0.05
Chronic obstructive pulmonary disease 33.6% 4.4% ,0.05
Weight 67.5 ± 12.3 72.3 ± 11.5 ,0.05
Body mass index 16 ± 2 22 ± 2 ,0.05
hematocrit 41.3 ± 5.7 40 ± 0.04 nS
Abbreviations: CSR, coronary sinus rupture; NS, not statistically significant.
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In the remaining patients, cardiopulmonary bypass was 
instituted immediately with systemic cooling to 30 °C, 
the aorta cross was clamped, and antegrade cardioplegia 
was given to arrest the heart. The heart was vented via 
the aortic root, the heart was gently retracted cephalad, 
and the coronary sinus area was examined carefully. If 
there was an intact subepicardial hematoma surround-
ing the coronary sinus, the decision was made to leave 
it undisturbed, and if the coronary sinus was torn, the 
decision was made to deflate the balloon, which was 
accomplished by leaving the balloon at the rupture site. 
If the rupture site was of small size, it was repaired edge 
to edge with 7-0 running Prolene sutures, and if the 
injury was large, an autologous pericardial patch repair 
was undertaken, as described by other surgeons.7
Two  of  our  15  patients  with  CSR  died.  In  the 
first case, we repaired the CSR after performing the 
distal graft and releasing the aortic cross clamp. As 
contraction  of  the  heart  started  and  the  heart  was 
lifted to the right to expose the coronary sinus, the 
heart  became  severely  edematous. The  long  pump 
time caused further damage to the heart and due to 
the friable and fragile wall of the coronary sinus and 
blood  in  the  field,  extension  of  the  CSR  occurred 
upon  movement  of  the  heart.  Because  of  multiple 
sutures and use of the pericardial patch, the coronary 
sinus became thrombosed and the heart was severely 
edematous. Due to coronary sinus obstruction, venous 
bleeding started from the suture line and in view of 
the severely edematous heart, the sternum was not 
closed until 48 hours later. About 30 units of whole 
blood, 20 units of fresh frozen plasma, 20 units of 
platelets, and 20 units of cryoprecipitate were given 
to control severe bleeding. After closing the sternum, 
the  patient  developed  acute  respiratory  distress 
syndrome  and  respiratory  failure.  At  last,  due  to 
unsuccessful weaning from ventilator, tracheostomy 
and pneumonia, the patient died.
In the other patient who died, CSR was caused by 
repeated attempts at cannula insertion, and rupture was 
secondary to traumatic stylus-guided   catheterization. 
The rupture extended to the atrioventricular groove 
and, despite pericardial patch repair, the situation was 
deemed notsalvageable and the patient died after a 
long pump time and in cardiac failure, and was not 
weaned from cardiopulmonary bypass.
Table 3. Multivariate regression analysis of CSr as dependent variables.
Variables B se Wald Df Significance Odds ratio
Age 0.038 0.019 3.961 1 0.047 1.039
Weight -0.040 0.016 6.217 1 0.013 0.960
Left main coronary disease -0.478 1.117 0.183 1 0.669 0.620
Body mass index 0.744 0.347 4.608 1 0.032 2.104
Female gender 1.443 0.533 7.326 1 0.007 4.235
Aortic clamp time 0.345 0.515 0.449 1 0.503 1.412
Aortic pump time 0.459 0.693 0.439 1 0.507 1.583
Constant -2.415 1.730 1.947 1 0.163 0.089
Abbreviations: CSr, coronary sinus rupture; Se, standard error of the mean.
Table 2. Comparison of intraoperative and postoperative variables by t-test and χ2.
Variable Group B  
(#70 years)
Group A  
(.70 years)
P value
Duration of hospital stay 17.5 ± 5.5 14.5 ± 7.5 nS
Pump time 102.8 ± 24 86.6 ± 18.5 ,0.05
Clamp time 65.9 ± 14.9 45 ± 12.3 ,0.05
Bleeding 6.9% 3.7% nS
renal complication 3.7% 2.1% nS
Pulmonary complication 14% 4.4% ,0.05
Death 13.3% 2.6% ,0.05
Infection 13.5% 3.5% ,0.05
Abbreviation: NS, not statistically significant.
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After our initial experiences of CSR repair using 
the beating onpump method, subsequent cases of CSR 
were repaired by arresting the heart with   cardioplegia, 
fixing a cannula in the CSR site to   prevent the return of 
venous blood and, because the surgical field was not 
bloody, we could repair the rupture using 7-0 Prolene 
with or without a pericardial patch. Fortunately, 13 of 
our 15 cases were repaired without any damage. In 
multivariate regression analysis, predictors of CSR 
include advancing age, female gender, weight, and 
body mass index, with odds ratios of 1.0, 4.2, 0.96, 
and 2.2, respectively. Female gender had the strongest 
effect on risk of CSR in CABG patients (Table 1).
Discussion
In certain situations, it is difficult to cannulate the 
coronary sinus for injection of cardioplegia, because 
it causes trauma at the entrance or along the coronary 
sinus,  or  because  of  inappropriate  distribution  of 
cardioplegia.  Ostial  valves  at  the  entrance  to  the 
coronary sinus will prevent entry of the cannula at 
this site.8 In the event of a persistent left superior 
vena cava, the coronary sinus will be hypoplastic, 
preventing  entry  of  the  cannula.  In  this  situation, 
injection of cardioplegia does not protect the heart, 
because most of the heart veins enter the right atrium 
directly.9 In cases of coronary sinus atresia, the veins 
of the heart drain directly into either the inominate 
vein,  the  left  superior  vena  cava,  the  left  atrium, 
or  the  thebesius  veins.10  If  the  hepatic  veins  enter 
the coronary sinus via the left superior vena cava, 
injection  of  cardioplegia  via  the  coronary  sinus  is 
not worthwhile, because the cardioplegia enters the 
pulmonary veins via a low pressure system and will not 
enter the veins of the heart, thus preventing uniform 
distribution of cardioplegia in the heart.6,11 If a fistula 
exists between the coronary sinus and the pulmonary 
sinus or left atrium, injection of cardioplegia does 
not  have  any  protective  effect,  and  sometimes  the 
connection  between  the  coronary  sinus  and  left 
atrium would be in the form of an unroofed coronary 
sinus.10 In the case of a left superior vena cava, and 
correct location of a retrograde cannula, the pressure 
of injection is low, and the heart would not arrest. In 
this situation, if the cannula is inserted forcefully, a 
rupture may occur in the coronary sinus.12 If the left 
superior vena cava enters the coronary sinus via the 
left jugular vein and if there is a connection between 
the left superior vena cava and the inominate veins, 
it is possible to protect the heart via cannulation of 
the coronary sinus after closing the left superior vena 
cava.5 If the surgeon is impatient or stressed during 
insertion of the retrograde cannula, the risk of CSR is 
increased. The risk also increases with female gender, 
fragile tissues, low body mass index, insertion of a 
large retrograde cannula into a small coronary sinus 
size, placement of the catheter tip in the distal third 
of the coronary sinus, and a high injection pressure 
(.50 mmHg).
conclusion
We  conclude  that  the  best  strategy  to  avoid  the 
potentially  lethal  complication  of  CSR  during 
CABG is prevention. Careful and cautious retrograde 
cannula insertion is essential, especially in thin female 
patients  with  fragile  arteries  and  low  body  mass 
index.  In  multivariate  regression  analysis,  female 
gender and low body mass index had a significant 
correlation with CSR. When difficulty is experienced 
during inserting of a retrograde cannula and repeated 
attempts have been made and were unsuccessful, it 
is best to avoid cannula insertion. If a CSR occurs, 
the best strategy is to inject antegrade cardioplegia, 
hold  the  retrograde  cannula  in  the  location  of  the 
rupture with an empty balloon cuff, and then sew the 
edges of the coronary sinus with 6-0 or 7-0 Prolene, 
or  undertake  a  pericardial  patch  repair.  However, 
it  should  be  remembered  that  sewing  of  the  CSR 
with an open aortic cross clamp when the surgical 
field is bloody and the heart is beating is likely to 
causes further damage to the coronary sinus and left 
circumflex coronary artery, as well as coronary sinus 
stenosis and thrombosis.
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